DuPont de Nemours (DD) Business News

Track DuPont de Nemours in real time with a live news feed covering DuPont de Nemours stock news, official press releases, company announcements, and an archive of historical DuPont de Nemours news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
4:30 PM | Tuesday | Oct 13, 2026 PRNewsWire

DuPont Announces Regular Quarterly Dividend on Common Stock

News Thumbnail
4:25 AM | Friday | Oct 9, 2026 Defense World

GAMMA Investing LLC Grows Stock Position in DuPont de Nemours, Inc. $DD

News Thumbnail
4:25 AM | Friday | Oct 9, 2026 Defense World

GAMMA Investing LLC Grows Stock Position in DuPont de Nemours, Inc. $DD

News Thumbnail
4:16 AM | Thursday | Oct 8, 2026 Defense World

Moody National Bank Trust Division Makes New Investment in DuPont de Nemours, Inc. $DD

News Thumbnail
10:14 AM | Tuesday | Oct 6, 2026 Defense World

DuPont de Nemours (NYSE:DD) & Marubeni (OTCMKTS:MARUY) Critical Analysis

News Thumbnail
7:00 AM | Tuesday | Oct 6, 2026 PRNewsWire

DuPont Schedules Third Quarter 2026 Earnings Conference Call

News Thumbnail
9:00 AM | Monday | Oct 5, 2026 PRNewsWire

DuPont Announces Winners of Third Annual Tyvek® Sustainable Healthcare Packaging Awards

News Thumbnail
10:15 AM | Sunday | Oct 4, 2026 Defense World

Mitsubishi (OTCMKTS:MSBHF) and DuPont de Nemours (NYSE:DD) Financial Survey

News Thumbnail
9:10 AM | Friday | Oct 2, 2026 Zacks Investment Research

DuPont Expands Sugar Separation Expertise With New Digital Tool

News Thumbnail
9:00 AM | Wednesday | Sep 30, 2026 PRNewsWire

DuPont Launches Sugar Separation Advisor to Accelerate Sugar and Sweetener Purification

News Thumbnail
2:19 PM | Thursday | Sep 24, 2026 Seeking Alpha

DuPont: Secular Growth And Margin Expansion Should Drive Good Upside

News Thumbnail
11:00 PM | Tuesday | Sep 22, 2026 GuruFocus

Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction

News Thumbnail

DuPont Announces Regular Quarterly Dividend on Common Stock

PRNewsWire

4:30 PM | Tuesday | Oct 13, 2026

news photo
Loading...

WILMINGTON, Del., Oct. 13, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on December 15, 2026, to holders of record of said stock at the close of business on November 30, 2026.

Read full article redirect
4:30 PM | Tuesday | Oct 13, 2026

DuPont Announces Regular Quarterly Dividend on Common Stock

PRNewsWire

WILMINGTON, Del., Oct. 13, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on December 15, 2026, to holders of record of said stock at the close of business on November 30, 2026.

Read full article arrow
News Thumbnail
4:25 AM | Friday | Oct 9, 2026

GAMMA Investing LLC Grows Stock Position in DuPont de Nemours, Inc. $DD

Defense World

GAMMA Investing LLC lifted its position in DuPont de Nemours, Inc. (NYSE: DD) by 242.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 26,978 shares of the basic materials company's stock after buying an additional 19,096 shares during

Read full article arrow
News Thumbnail
4:25 AM | Friday | Oct 9, 2026

GAMMA Investing LLC Grows Stock Position in DuPont de Nemours, Inc. $DD

Defense World

GAMMA Investing LLC lifted its position in DuPont de Nemours, Inc. (NYSE: DD) by 242.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 26,978 shares of the basic materials company's stock after buying an additional 19,096 shares during

Read full article arrow
News Thumbnail
4:16 AM | Thursday | Oct 8, 2026

Moody National Bank Trust Division Makes New Investment in DuPont de Nemours, Inc. $DD

Defense World

Moody National Bank Trust Division purchased a new position in shares of DuPont de Nemours, Inc. (NYSE: DD) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 5,461 shares of the basic materials company's stock, valued at approximately $709,000. A number of

Read full article arrow
News Thumbnail
10:14 AM | Tuesday | Oct 6, 2026

DuPont de Nemours (NYSE:DD) & Marubeni (OTCMKTS:MARUY) Critical Analysis

Defense World

DuPont de Nemours (NYSE: DD - Get Free Report) and Marubeni (OTCMKTS:MARUY - Get Free Report) are both large-cap industrials companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Profitability This table compares DuPont de Nemours

Read full article arrow
News Thumbnail
7:00 AM | Tuesday | Oct 6, 2026

DuPont Schedules Third Quarter 2026 Earnings Conference Call

PRNewsWire

WILMINGTON, Del., Oct. 6, 2026 /PRNewswire/ -- DuPont (NYSE: DD) will release its third quarter 2026 financial results at 6:00 a.m.

Read full article arrow
News Thumbnail
9:00 AM | Monday | Oct 5, 2026

DuPont Announces Winners of Third Annual Tyvek® Sustainable Healthcare Packaging Awards

PRNewsWire

Awards recognize continued excellence in healthcare packaging initiatives that utilize Tyvek ® material to help drive and promote sustainable innovation WILMINGTON, Del., Oct. 5, 2026 /PRNewswire/ -- DuPont (NYSE: DD) announced the winners of its global awards program, the Tyvek® Sustainable Healthcare Packaging Awards, during the Medical Packaging Conference (MPC) hosted by DuPont September 30 - October 2, 2026, in Boston.

Read full article arrow
News Thumbnail
10:15 AM | Sunday | Oct 4, 2026

Mitsubishi (OTCMKTS:MSBHF) and DuPont de Nemours (NYSE:DD) Financial Survey

Defense World

DuPont de Nemours (NYSE: DD - Get Free Report) and Mitsubishi (OTCMKTS:MSBHF - Get Free Report) are both large-cap industrials companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership. Profitability This table compares DuPont de Nemours

Read full article arrow
News Thumbnail
9:10 AM | Friday | Oct 2, 2026

DuPont Expands Sugar Separation Expertise With New Digital Tool

Zacks Investment Research

DD launches a digital tool using chromatography data to help sugar and sweetener makers assess separation options and identify resins.

Read full article arrow
News Thumbnail
9:00 AM | Wednesday | Sep 30, 2026

DuPont Launches Sugar Separation Advisor to Accelerate Sugar and Sweetener Purification

PRNewsWire

Digital tool draws on extensive laboratory separation data to help sugar and sweetener producers identify best-fit DuPont™ AmberLite™ chromatography resins for Food & Beverage ingredient applications. WILMINGTON, Del.

Read full article arrow
News Thumbnail
2:19 PM | Thursday | Sep 24, 2026

DuPont: Secular Growth And Margin Expansion Should Drive Good Upside

Seeking Alpha

DuPont is rated Buy, offering secular growth and margin expansion at an attractive valuation, with strong exposure to healthcare, water, EV, and aerospace markets. Healthcare and Water Technologies drive structural growth, supported by leading positions in medical devices and semiconductor water treatment, with resilient recurring revenues. The Diversified Industrials segment benefits from EV battery adhesives and aerospace, with growth initiatives and margin expansion through 80/20 simplification and productivity programs.

Read full article arrow
News Thumbnail
11:00 PM | Tuesday | Sep 22, 2026

Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction

GuruFocus

Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reductio

Read full article arrow
News Thumbnail